These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1629833)

  • 1. Transient myopia with severe chemosis associated with exacerbation of disease activity in systemic lupus erythematosus.
    Shu U; Takeuchi F; Tanimoto K; Moroi Y; Uchida K; Ito K
    J Rheumatol; 1992 Feb; 19(2):297-301. PubMed ID: 1629833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient high myopia in systemic lupus erythematosus associated with anasarca.
    Ayazi S; Armstrong WL; Weinstein A
    Ann Ophthalmol; 1982 Aug; 14(8):785-7. PubMed ID: 7125476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral transient keratoendotheliitis associated with systemic lupus erythematosus.
    Varga JH; Wolf TC
    Ann Ophthalmol; 1993 Jun; 25(6):222-3. PubMed ID: 8338317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibody-negative systemic lupus erythematosus (SLE) and severe renal involvement: close correlation between disease activity and appearance of circulating anticoagulant.
    Raz E; Michaeli J; Rosenmann E; Rubinow A; Popovtzer MM
    Isr J Med Sci; 1988 Feb; 24(2):105-8. PubMed ID: 3128493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus. Management during pregnancy.
    Zurier RB; Argyros TG; Urman JD; Warren J; Rothfield NF
    Obstet Gynecol; 1978 Feb; 51(2):178-80. PubMed ID: 304545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in levels of antibodies against the 70 kDa and a polypeptides of the U1RNP complex in relation to exacerbations of systemic lupus erythematosus.
    ter Borg EJ; Horst G; Limburg PC; van Venrooij WJ; Kallenberg CG
    J Rheumatol; 1991 Mar; 18(3):363-7. PubMed ID: 1830337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S; Harper J; Kiely PD
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoidosis: atypical presentation associated with features of systemic lupus erythematosus.
    Askari A; Thompson P; Barnes C
    J Rheumatol; 1988 Oct; 15(10):1578-9. PubMed ID: 3264582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient myopia with severe chemosis as an initial manifestation of systemic lupus erythematosus.
    Bohgaki T; Mukai M; Notoya A; Kondo M; Kohno M; Okushiba U
    Mod Rheumatol; 2001 Jun; 11(2):165-7. PubMed ID: 24383697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral periorbital edema in systemic lupus erythematosus.
    Norden D; Weinberg J; Schumacher HR; Keenan G; Freundlich B
    J Rheumatol; 1993 Dec; 20(12):2158-60. PubMed ID: 8014949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC; Malone CC; Meyers C; Decker P; Muller S
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
    Ward MM; Dooley MA; Christenson VD; Pisetsky DS
    J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periorbital edema in systemic lupus erythematosus.
    Smith CA; Pinals RS
    Arch Intern Med; 1982 Sep; 142(9):1711-2. PubMed ID: 7114990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.